Cataldo, I., Sarcognato, S., Sacchi, D., Cacciatore, M., Baciorri, F., & Mangia, A., et al. (2021). Pathology of non-alcoholic fatty liver disease. Pathologica, 113(3), 194–202.

Article  PubMed  PubMed Central  Google Scholar 

Targher, G., Byrne, C. D., & Tilg, H. (2020). NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut, 69(9), 1691–705.

Article  CAS  PubMed  Google Scholar 

Abdelmalek, M. F. (2021). Nonalcoholic fatty liver disease: another leap forward. Nature Reviews Gastroenterology & Hepatology, 18(2), 85–6.

Article  Google Scholar 

Huang, T. D., Behary, J., & Zekry, A. (2020). Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Internal Medicine Journal, 50(9), 1038–47.

Article  PubMed  Google Scholar 

Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., & Yang, W., et al. (2022). Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocrine Disorders, 22(1), 63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bansal, R., Mandrekar, P., Mohanty, S. K., & Weiskirchen, R. (2020). Editorial: Macrophages in liver disease. Frontiers in Immunology, 11, 1754.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van der Heide, D., Weiskirchen, R., & Bansal, R. (2019). Therapeutic targeting of hepatic macrophages for the treatment of liver diseases. Frontiers in Immunology, 10, 2852.

Article  PubMed  PubMed Central  Google Scholar 

Laursen, T. L., Mellemkjær, A., Møller, H. J., Grønbæk, H., & Kazankov, K. (2022). Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease. Expert Opinion on Therapeutic Targets, 26(8), 697–705.

Article  PubMed  Google Scholar 

Thibaut, R., Gage, M. C., Pineda-Torra, I., Chabrier, G., Venteclef, N., & Alzaid, F. (2022). Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease. The FEBS Journal, 289(11), 3024–57.

Article  CAS  PubMed  Google Scholar 

Cai, B., Dongiovanni, P., Corey, K. E., Wang, X., Shmarakov, I. O., & Zheng, Z., et al. (2020). Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis. Cell Metabolism, 31(2), 406–21.e7.

Article  CAS  PubMed  Google Scholar 

Du, S., Zhang, X., Jia, Y., Peng, P., Kong, Q., & Jiang, S., et al. (2023). Hepatocyte HSPA12A inhibits macrophage chemotaxis and activation to attenuate liver ischemia/reperfusion injury via suppressing glycolysis-mediated HMGB1 lactylation and secretion of hepatocytes. Theranostics, 13(11), 3856–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv, S., Zhang, Z., Su, X., Li, W., Wang, X., & Pan, B., et al. (2022). Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway. Frontiers in Endocrinology, 13, 1106875.

Article  PubMed  Google Scholar 

Chen, S., Li, X., Li, M., Mei, Q., Huang, J., & Wu, Z., et al. (2020). Mucosal expression of defensin-5, soluble phospholipase A2 and lysozyme in the intestine in a rat model of acute liver failure and its relationship to intestinal bacterial translocation. Gastroenterologia y hepatologia, 43(6), 293–300.

Article  PubMed  Google Scholar 

Franz, S., Ertel, A., Engel, K. M., Simon, J. C., & Saalbach, A. (2022). Overexpression of S100A9 in obesity impairs macrophage differentiation via TLR4-NFkB-signaling worsening inflammation and wound healing. Theranostics, 12(4), 1659–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Apostolova, E., Lukova, P., Baldzhieva, A., Delattre, C., Molinié, R., Petit, E., et al. Structural characterization and in vivo anti-inflammatory activity of fucoidan from cystoseira crinita (Desf.) Borry. Marine Drugs. 2022;20(11).

Wang, K., Cui, X., Ling, X., Chen, J., Zheng, J., Xiang, Y., et al. D-Xylose blocks the broad negative regulation of XylR on lipid metabolism and affects multiple physiological characteristics in mycobacteria. International Journal of Molecular Sciences 2023;24(8).

Zeigerer, A. (2021). NAFLD - A rising metabolic disease. Molecular Metabolism, 50, 101274.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, J., Wu, C., Li, X., Yan, Q., Reaney, M. J. T., & Jiang, Z. (2019). Xylose rich heteroglycan from flaxseed gum mediates the immunostimulatory effects on macrophages via TLR2 activation. Carbohydrate Polymers, 213, 59–69.

Article  CAS  PubMed  Google Scholar 

Li, J., Wang, T., Liu, P., Yang, F., Wang, X., & Zheng, W., et al. (2021). Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food & Function, 12(9), 3898–918.

Article  CAS  Google Scholar 

Hu, J., Wu, Y., Kang, L., Liu, Y., Ye, H., & Wang, R., et al. (2023). Dietary D-xylose promotes intestinal health by inducing phage production in Escherichia coli. NPJ Biofilms and Microbiomes, 9(1), 79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, Y., Zhao, D., Qian, M., Liu, J., Pan, C., & Zhang, X., et al. (2022). Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota. British Journal of Pharmacology, 179(9), 2054–77.

Article  CAS  PubMed  Google Scholar 

Li, W., & Alazawi, W. (2020). Non-alcoholic fatty liver disease. Clinical Medicine (London, England), 20(5), 509–12.

Article  PubMed  Google Scholar 

McNeice, K., & Sandberg, K. (2020). Updates in non-alcoholic fatty liver disease (NAFLD). Current Problems in Pediatric and Adolescent Health Care, 50(8), 100844.

Article  PubMed  Google Scholar 

Paternostro, R., & Trauner, M. (2022). Current treatment of non-alcoholic fatty liver disease. Journal of Internal Medicine, 292(2), 190–204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elchaninov, A. V., Fatkhudinov, T. K., Vishnyakova, P. A., Lokhonina, A. V., Sukhikh, G. T. Phenotypical and functional polymorphism of liver resident macrophages. Cells 2019;8(9).

Gentek, R., Molawi, K., & Sieweke, M. H. (2014). Tissue macrophage identity and self-renewal. Immunological Reviews, 262(1), 56–73.

Article  CAS  PubMed  Google Scholar 

Guilliams, M., & Scott, C. L. (2022). Liver macrophages in health and disease. Immunity, 55(9), 1515–29.

Article  CAS  PubMed  Google Scholar 

Venkata Subbiah, H., Ramesh Babu, P., & Subbiah, U. (2022). Determination of deleterious single-nucleotide polymorphisms of human LYZ C gene: An in silico study. Journal Genetic Engineering & Biotechnology, 20(1), 92.

Article  Google Scholar 

Gu, Z., Wang, L., Dong, Q., Xu, K., Ye, J., & Shao, X., et al. (2023). Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78. Proceedings of the National Academy of Sciences of the United States of America, 120(29), e2215744120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shan, Z., & Ju, C. (2020). Hepatic macrophages in liver injury. Frontiers in immunology, 11, 322.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shapouri-Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S. A., & Mardani, F., et al. (2018). Macrophage plasticity, polarization, and function in health and disease. Journal of cellular physiology, 233(9), 6425–40.

Article  CAS  PubMed  Google Scholar 

Sheu, K. M., & Hoffmann, A. (2022). Functional hallmarks of healthy macrophage responses: Their regulatory basis and disease relevance. Annual Review of Immunology, 40, 295–321.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, W., Wang, X., Huang, L. I., & Liu, B. O. (2016). Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway. Experimental and Therapeutic Medicine, 11(1), 73–6.

Article  CAS